3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Head and Neck Neoplasms
1
Agnosia
1
Interventions
pembrolizumab
67
Cyclophosphamide
45
Cisplatin
45
Nivolumab
39
Paclitaxel
35
Carboplatin
31
Radiotherapy
30
Gemcitabine
28
Docetaxel
27
Dexamethasone
23
atezolizumab
22
Bevacizumab
20
Doxorubicin
19
Vincristine
17
Magnetic Resonance Spectroscopy
17
Lenalidomide
17
fludarabine
16
Radiosurgery
16
Fluorouracil
16
Etoposide
16
Blood Specimen Collection
16
Rituximab
15
Radiation
15
Letrozole
15
Irinotecan
15
Ipilimumab
15
palbociclib
14
Leucovorin
14
Cytarabine
14
Surveys and Questionnaires
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Ketoprofen
×
90 days
×
Clear all
NCT02439034
2026-03-16
KETOCOL
Centre Oscar Lambret
Phase 2
Completed
68 enrolled